The safety of JAK-1 inhibitorsReview Published on 2021-05-052023-06-01 Journal: Rheumatology (Oxford, England) [Category] [DOI] 10.1093/rheumatology/keaa895 PMC 바로가기 [Article Type] Review
Compassionate use of ruxolitinib in patients with SARS-Cov-2 infection not on mechanical ventilation: Short-term effects on inflammation and ventilation기계적 환기가 아닌 SARS-Cov-2 감염 환자에서 룩소리티닙의 동정적 사용: 염증 및 환기에 대한 단기 영향Article Published on 2021-05-012022-09-11 Journal: Clinical and translational science [Category] [DOI] 10.1111/cts.12971 PMC 바로가기 [Article Type] Article
SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivationSARS-CoV-2는 JAK1/2 종속 국소 보체 과활성화를 유도합니다.Research Articles Published on 2021-04-072022-09-12 Journal: Science Immunology [Category] [DOI] 10.1126/sciimmunol.abg0833 PMC 바로가기 [Article Type] Research Articles
Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infectionMini‐Review|Clinical Published on 2021-03-222022-10-31 Journal: European Journal of Immunology [Category] [DOI] 10.1002/eji.202149173 PMC 바로가기 [Article Type] Mini‐Review|Clinical
Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?COVID-19 발생 시 류마티스 질환에 대한 생물학적 제제: 친구 또는 적?Observational Study Published on 2021-01-012022-09-12 Journal: RMD Open [Category] [DOI] 10.1136/rmdopen-2020-001439 PMC 바로가기 [Article Type] Observational Study
Ruxolitinib for Severe COVID-19-Related Hyperinflammation in Nonresponders to Steroids스테로이드에 반응하지 않는 환자의 중증 COVID-19 관련 과염증에 대한 룩소리티닙Article Published on 2021-01-012022-09-12 Journal: Acta haematologica [Category] [DOI] 10.1159/000516464 PMC 바로가기 [Article Type] Article
A systematic review on treatment-related mucocutaneous reactions in COVID-19 patientsCOVID-19 환자의 치료 관련 점막 피부 반응에 대한 체계적인 검토Article Published on 2021-01-012022-09-11 Journal: Dermatologic therapy [Category] [DOI] 10.1111/dth.14662 PMC 바로가기 [Article Type] Article
JAK inhibitors for the treatment of rheumatoid arthritisReview Published on 2020-12-012023-06-02 Journal: Immunological medicine [Category] [DOI] 10.1080/25785826.2020.1770948 PMC 바로가기 [Article Type] Review
Immunotherapeutic approaches to curtail COVID-19Article Published on 2020-08-212022-10-04 Journal: International immunopharmacology [Category] [DOI] 10.1016/j.intimp.2020.106924 PMC 바로가기 [Article Type] Article
How COVID-19 affects patients receiving anticytokine and JAK inhibitors in rheumatology and dermatologyCommentary Published on 2020-07-092022-10-31 Journal: Immunotherapy [Category] [DOI] 10.2217/imt-2020-0153 PMC 바로가기 [Article Type] Commentary